Results 41 to 50 of about 14,147 (241)
Asian Journal of Surgery, 2019 Summary: Background/Purpose: Pleurodesis with biomaterial implant is an emerging treatment method for pleural diseases. However, the ideal biomaterial or the optimal form for the common diseases is still under investigation.
Cheng-Hung How +5 more
doaj +1 more source
The Egyptian Journal of Bronchology, 2020 Background Researches to detect the ideal agent for pleurodesis are still continuous; iodopovidone is one of the best agents for pleurodesis that are commonly used.
Ayman H. Abd El Zaher, Ayman S. El Dib
doaj +1 more source
Egyptian Journal of Chest Disease and Tuberculosis, 2022 Background Malignant pleural effusion (MPE) is prevalent, and in cases such as aging patients as well as increased long-term survival for metastatic cancers, the number of patients will continue to elevate in the near future.
Adel M Saeed +3 more
doaj +1 more source
Determination of In Vivo efficacy and safety of zeolite as a new pleurodesis agent
Toxicology Reports, 2022 Pleural effusion, the pathological condition in which an abnormal amount of pleural fluid is accumulated in the small space between the visceral and parietal pleurae of the lungs, can be treated by pleurodesis, whereby the pleural space is obliterated ...
Engin Sumer +5 more
doaj +1 more source
Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. [PDF]
PLoS ONE, 2014 BACKGROUND: Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies.
Huan Xia +4 more
doaj +1 more source
World Journal of Surgical Oncology, 2020 Background Talc pleurodesis (TP) and indwelling pleural catheter (IPC) are used for the management of malignant pleural effusion (MPE). Our meta-analysis was conducted to assess the efficacy and safety of both treatments among patients with MPE.
Li Wang +6 more
semanticscholar +1 more source
Expert Review of Respiratory Medicine, 2020 Objectives Pleurodesis is an important management option to palliate breathlessness in patients with malignant pleural effusion (MPE). This systematic review aimed to examine available literature for studies investigating factors that predict pleurodesis
Maged Hassan +4 more
semanticscholar +1 more source
European Journal of Cardio-Thoracic Surgery, 2020 OBJECTIVES Surgical management of spontaneous pneumothorax typically involves wedge resection and mechanical pleurodesis. It is unclear whether combining mechanical and chemical pleurodesis can further reduce the recurrence rate. We have performed a meta-
A. Asban +4 more
semanticscholar +1 more source
PERBANDINGAN EFEKTIFITAS HASIL PLEURODESIS CEPAT DAN PLEURODESIS PROSEDUR STANDAR PADA PENDERITA EFUSI PLEURA KARENA KEGANASAN [PDF]
, 2018 Latar belakang: Stadium terminal dari NSCLC berkaitan dengan metastasis jauh serta didapatkannya malignant pleural effusion (MPE) yang merupakan penyulit pada sekitar 25-50% kasus kanker paru.
Andri Dwi Wahyudi
core +1 more source
Thoracic Cancer, 2020 Pleurodesis is the standard of care for non‐small cell lung cancer (NSCLC) patients with symptomatic malignant pleural effusion (MPE). However, there is no standard management for MPE uncontrolled by pleurodesis.
R. Noro +12 more
semanticscholar +1 more source